GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 8,159.2 million compared to INR 7,918.7 million a year ago. Revenue was INR 8,262.4 million compared to INR 8,058.9 million a year ago. Net income was INR 1,503.5 million compared to INR 1,565.1 million a year ago. Basic earnings per share from continuing operations was INR 8.16 compared to INR 8.22 a year ago. Basic earnings per share was INR 8.88 compared to INR 9.24 a year ago.
For the nine months, sales was INR 24,684 million compared to INR 21,811.7 million a year ago. Revenue was INR 25,254.2 million compared to INR 22,621.5 million a year ago. Net income was INR 4,756.7 million compared to INR 3,438.2 million a year ago. Basic earnings per share from continuing operations was INR 25.7 compared to INR 16.74 a year ago. Basic earnings per share was INR 28.08 compared to INR 20.3 a year ago.